{
  "meta": {
    "title": "Metabolic_Disorders_Endocrinology",
    "url": "https://brainandscalpel.vercel.app/metabolic-disorders-endocrinology-003ac1dd.html",
    "scrapedAt": "2025-11-30T11:19:26.522Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynecomastia</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Raised intracranial pressure</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Transient hypothyroidism</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 diabetes mellitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a recognised side effect of growth hormone (GH) therapy?</span></p>",
      "unique_key": "DT1230319",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230319,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Growth hormone (GH) therapy is associated with metabolic and skeletal side effects, but <strong>type 1 diabetes mellitus is not a known complication</strong>.</p>\n<ul>\n<li>GH increases insulin resistance and may predispose to <strong>type 2 diabetes</strong>, particularly in at-risk individuals.</li>\n<li>There is <strong>no established link between GH therapy and the development of type 1 diabetes</strong>, which is an autoimmune condition.</li>\n<li>Common side effects include:\n<ul>\n<li><strong>Pseudotumor cerebri</strong> (benign intracranial hypertension)</li>\n<li><strong>Gynecomastia</strong></li>\n<li><strong>Slipped capital femoral epiphysis (SCFE)</strong></li>\n<li><strong>Exacerbation of scoliosis</strong></li>\n<li><strong>Reversible (transient) central hypothyroidism</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>GH improves glucose homeostasis in GH-deficient children by normalising fasting and postprandial insulin levels.</li>\n<li>The risk of type 2 diabetes is increased in children with risk factors like obesity, family history, or Turner syndrome.</li>\n<li>Close monitoring of glucose metabolism is advised during therapy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Gynecomastia (Option A):</strong> Reported side effect due to hormonal shifts during GH therapy.</p>\n<p><strong>Raised intracranial pressure (Option B):</strong> A documented complication presenting as headache or visual disturbances.</p>\n<p><strong>Transient hypothyroidism (Option C):</strong> GH can unmask underlying central hypothyroidism, typically reversible with continued treatment.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>GH therapy can cause type 2 but not type 1 diabetes; the latter is not a recognised side effect.</strong></p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Send the patient to the emergency department for CT evaluation of the brain</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Obtain the growth hormone level</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Obtain IGF-1 level</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Start growth hormone injections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old girl is 4 ft 10 in (147 cm) tall. Her father is 5 ft 10 in (178 cm) tall, and her mother is 5 ft 5 in (165 cm) tall. Over the past 3 years, she has dropped from the 25th percentile for height to the 5th percentile. Her weight has remained stable. Radiographs show delayed bone age. Which of the following is the most appropriate next step in her management?</span></p>",
      "unique_key": "DT1230411",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230411,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A declining growth velocity with delayed bone age in the context of normal weight raises concern for <strong>growth hormone deficiency (GHD)</strong>. The best initial screening test is <strong>IGF-1 level</strong>, which reflects integrated GH secretion and is not subject to pulsatility.</p>\n<ul>\n<li>GH secretion is pulsatile and unreliable for diagnosis if measured directly.</li>\n<li>A low IGF-1 suggests GH deficiency and warrants referral for GH stimulation testing.</li>\n<li>A CT scan is unnecessary unless there are neurological symptoms.</li>\n<li>GH treatment should only begin after a confirmed diagnosis.</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>In GHD, height is disproportionately low compared to weight.</li>\n<li>Bone age delay is typical.</li>\n<li>The GH stimulation test is done only if IGF-1 is low.</li>\n<li>Constitutional growth delay is characterised by delayed bone age but normal growth velocity.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Send patient to ED for CT evaluation (Option A):</strong> No neurological symptoms, CT not indicated.</p>\n<p><strong>Obtain growth hormone level (Option B):</strong> GH secretion is pulsatile; basal GH levels are not reliable.</p>\n<p><strong>Start GH injections (Option D):</strong> Treatment is inappropriate before diagnostic confirmation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>In suspected GH deficiency with delayed bone age and falling growth percentile, IGF-1 is the best first-line screening test.</strong></p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">21-hydroxylase deficiency</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxylase deficiency</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">17&alpha;-hydroxylase deficiency</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">3&beta;-hydroxysteroid dehydrogenase deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-week-old male child is found to have hypoglycemia, hyperpigmented scrotum, hyponatremia, and a shock-like state. The external genitalia appear female-like. Which of the following enzyme deficiencies is most likely?</span></p>",
      "unique_key": "DT1230321",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230321,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The child shows features of salt-wasting crisis (hyponatremia, shock) along with ambiguous genitalia in a <strong>genotypic male</strong>, which strongly suggests <strong>3&beta;-HSD deficiency</strong>.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090747f976e7-ef96-4476-abf3-fb8a9d8f96bc.png\">\n<ul>\n<li>In <strong>3&beta;-hydroxysteroid dehydrogenase (3&beta;-HSD) deficiency</strong>, the synthesis of cortisol, aldosterone, and testosterone is impaired.</li>\n<li>DHEA (a weak androgen) is increased &rarr; causing <strong>mild virilisation in females</strong> and <strong>incomplete masculinization in males</strong>.</li>\n<li>Classic form causes <strong>salt-wasting crisis</strong> and <strong>ambiguous genitalia in both sexes</strong>.</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li><strong>Elevated DHEA and 17-hydroxypregnenolone</strong> are biochemical hallmarks.</li>\n<li>Requires <strong>hydrocortisone + fludrocortisone </strong>replacement.</li>\n<li>The mutation is in the <strong>HSD3B2 gene</strong> on chromosome 1p13.1.</li>\n<li>Extremely rare (&lt;2% of all CAH cases).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>21-hydroxylase deficiency (Option A):</strong> Salt-wasting with virilisation, but males have normal genitalia.</p>\n<p><strong>11&beta;-hydroxylase deficiency (Option B):</strong> Causes <strong>hypertension</strong> and virilisation, not salt-wasting.</p>\n<p><strong>17&alpha;-hydroxylase deficiency (Option C):</strong> Causes <strong>hypertension</strong>, undervirilization, but <strong>no salt-wasting</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>3&beta;-HSD deficiency causes ambiguous genitalia in both sexes and salt-wasting crisis in neonates.</strong></p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">21-hydroxylase</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">17&beta;-hydroxylase</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxylase</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">17&alpha;-hydroxylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female neonate presents with ambiguous genitalia. Laboratory evaluation shows:<br>Serum 17-hydroxyprogesterone: >10,000 ng/dL<br>Serum progesterone: markedly elevated<br>Serum sodium: 128 mEq/L, potassium: 6.5 mEq/L<br>USG abdomen: normal uterus and ovaries<br>Which of the following enzyme deficiencies is most likely responsible?</span></p>",
      "unique_key": "DT1230384",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230384,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This is a classic case of <strong>salt-wasting Congenital Adrenal Hyperplasia (CAH)</strong> due to <strong>21-hydroxylase deficiency</strong>, the most common form of CAH (&gt;90% cases).</p>\n<ul>\n<li>In <strong>21-hydroxylase deficiency</strong>, cortisol and aldosterone synthesis are impaired.</li>\n<li>Steroid precursors (especially <strong>17-hydroxyprogesterone</strong>) accumulate and are shunted into the <strong>androgen pathway</strong>, leading to:\n<ul>\n<li><strong>Elevated testosterone</strong></li>\n<li><strong>Virilisation of female external genitalia</strong> (clitoromegaly, labioscrotal fusion)</li>\n</ul>\n</li>\n<li>Salt-wasting occurs due to <strong>aldosterone deficiency</strong>, leading to:\n<ul>\n<li><strong>Hyponatremia</strong>, <strong>hyperkalemia</strong>, and <strong>dehydration</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Ultrasound findings</strong>: Internal female organs (uterus, ovaries) are <strong>present</strong>, helping rule out androgen insensitivity syndrome.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907fb95ac80-a139-4869-bc91-8b467668ef09.png\">\n<ul>\n<li>Diagnosis confirmed with <strong>17-OHP assay</strong></li>\n<li>Treatment: <strong>Hydrocortisone</strong>, <strong>fludrocortisone</strong>, and <strong>salt replacement</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>17&beta;-hydroxylase (Option B):</strong> Causes undervirilization in males and hypertension, not ambiguous genitalia in females.</p>\n<p><strong>11&beta;-hydroxylase (Option C):</strong> Also causes virilisation but is associated with <strong>hypertension</strong>, not salt-wasting.</p>\n<p><strong>17&alpha;-hydroxylase (Option D):</strong> Causes <strong>hypertension and sexual infantilism</strong>, not ambiguous genitalia with salt-wasting.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>21-hydroxylase deficiency</strong> presents with ambiguous genitalia in females, salt-wasting crisis, and elevated 17-OHP levels.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">21-hydroxylase deficiency</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">3&beta;-hydroxysteroid dehydrogenase deficiency</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxylase deficiency</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Conn's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old girl presents with progressive virilisation, hypertension, hypernatremia, and hypokalemia. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1230386",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230386,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The triad of hypertension, virilisation, and hypokalemia in a child strongly suggests 11&beta;-hydroxylase deficiency.</p>\n<ul>\n<li>In 11&beta;-hydroxylase deficiency, excess <strong>11-deoxycorticosterone (DOC)</strong>, a <strong>potent mineralocorticoid</strong>, causes <strong>sodium retention</strong>, <strong>hypertension</strong>, and <strong>hypokalemia</strong>.</li>\n<li>Simultaneously, steroid precursors are diverted into <strong>androgen synthesis</strong>, causing <strong>virilisation</strong> in females.</li>\n<li><strong>Aldosterone is suppressed</strong> due to feedback inhibition, but mineralocorticoid activity is maintained by DOC.</li>\n<li>The typical presentation is a child with <strong>early-onset hypertension</strong> and <strong>ambiguous or virilized genitalia</strong> (especially in genetic females).</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090719e028de-dc97-415a-bbfa-02ca3a831d9f.png\">\n<ul>\n<li><strong>Conn disease</strong> (aldosterone-producing adenoma) occurs in adults and <strong>does not cause virilisation</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>21-hydroxylase deficiency (Option A):</strong> Causes <strong>salt-wasting</strong> and hypotension; hypertension is not seen.</p>\n<p><strong>3&beta;-hydroxysteroid dehydrogenase deficiency (Option B):</strong> Also causes <strong>salt-wasting</strong> and ambiguous genitalia.</p>\n<p><strong>Conn's disease (Option D):</strong> Primary aldosteronism in adults; <strong>does not cause virilisation</strong> or present in children.</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">17-hydroxyprogesterone</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Renin</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-week-old male infant with normal genitalia presents to the emergency department with severe dehydration, hyponatremia, and hyperkalemia. Which of the following investigations would be most helpful in establishing the diagnosis?</span></p>",
      "unique_key": "DT1230387",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230387,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In a neonate with salt-wasting and normal genitalia, an elevated 17-hydroxyprogesterone level strongly suggests 21-hydroxylase deficiency.</p>\n<ul>\n<li>The child presents with <strong>salt-losing crisis</strong>:\n<ul>\n<li><strong>Hyponatremia</strong>, <strong>hyperkalemia</strong>, and <strong>dehydration</strong></li>\n<li>Suggests <strong>mineralocorticoid deficiency</strong> (aldosterone &darr;)</li>\n</ul>\n</li>\n<li>The <strong>most common cause</strong> in neonates is <strong>21-hydroxylase deficiency (CAH)</strong>\n<ul>\n<li>In males, the genitalia are usually <strong>normal</strong></li>\n<li>In females, <strong>virilisation</strong> is typically present</li>\n</ul>\n</li>\n<li>The diagnostic marker:\n<ul>\n<li><strong>&uarr; 17-hydroxyprogesterone</strong> due to an enzymatic block</li>\n<li>It's used in <strong>newborn screening</strong> programs worldwide<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509075216dd39-fbc5-454c-882b-607871613fc6.png\"></li>\n</ul>\n</li>\n<li>Confirmatory test: <strong>17-hydroxyprogesterone assay</strong></li>\n<li>Management: <strong>Hydrocortisone</strong>, <strong>fludrocortisone</strong>, and salt replacement</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Renin (Option B):</strong> May be elevated, but is nonspecific and follows salt loss.</p>\n<p><strong>Cortisol (Option C):</strong> Low in CAH but not as specific as 17-OHP.</p>\n<p><strong>Aldosterone (Option D):</strong> Decreased in CAH but not diagnostic alone.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>17-hydroxyprogesterone is the most reliable diagnostic marker for 21-hydroxylase deficiency in neonates.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycaemia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal genitalia</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased DHEA</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased androstenedione</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male child with 3 beta-hydroxysteroid dehydrogenase deficiency cannot have which among the following?</span></p>",
      "unique_key": "DT1230420",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230420,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>3&beta;-hydroxysteroid dehydrogenase deficiency always causes ambiguous genitalia in both males and females due to impaired synthesis of testosterone and cortisol.</p>\n<ul>\n<li>This condition impairs the conversion of pregnenolone to progesterone, and 17-hydroxypregnenolone to 17-hydroxyprogesterone.</li>\n<li>Resulting hormonal pattern:\n<ul>\n<li>Low cortisol &rarr; increased ACTH &rarr; adrenal hyperplasia</li>\n<li>Low aldosterone &rarr; salt-wasting crisis</li>\n<li>Low androstenedione &rarr; ambiguous genitalia in both sexes</li>\n<li>High DHEA levels &rarr; shunted towards adrenal androgens but ineffective testosterone synthesis</li>\n</ul>\n</li>\n<li>Hence, normal male genitalia is not possible.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202410078fd91104-f1c3-4273-9176-5fedd622d013.jpg\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hypoglycaemia (Option A):</strong> Due to cortisol deficiency, hypoglycemia is common.</p>\n<p><strong>Increased DHEA (Option C):</strong> Precursor buildup causes elevated DHEA levels.</p>\n<p><strong>Decreased androstenedione (Option D):</strong> This is a typical feature due to impaired synthesis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Normal male genitalia is not possible in 3&beta;-HSD deficiency due to decreased androgen production.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle phosphorylase</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogen phosphorylase</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphatase</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Acid maltase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child has been diagnosed with Pompe disease. Which of the following enzyme deficiencies is responsible?</span></p>",
      "unique_key": "DT1230323",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Pompe disease (Glycogen Storage Disease Type II)</strong> is caused by a deficiency of <strong>acid maltase</strong>, also known as <strong>lysosomal &alpha;-1,4-glucosidase</strong>. This leads to lysosomal accumulation of glycogen in various organs, especially the <strong>heart</strong> and <strong>skeletal muscles</strong>.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509079a6b20be-74ec-450d-b9c4-09237162992c.png\">\n<ul>\n<li>In Pompe disease, glycogen accumulates in lysosomes.</li>\n<li>Leads to <strong>cardiomegaly</strong>, <strong>hypotonia</strong>, and <strong>early death</strong> in the infantile form.</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>Pompe is <strong>unique</strong> among GSDs because it is <strong>lysosomal</strong>, not cytoplasmic.</li>\n<li>Unlike Von Gierke or McArdle, it affects <strong>multiple organ systems</strong>, especially the <strong>heart</strong>.</li>\n<li>Diagnosed by <strong>enzyme assay</strong> or <strong>genetic testing</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Muscle phosphorylase (Option A):</strong> Deficient in <strong>McArdle disease (GSD V)</strong>.</p>\n<p><strong>Glycogen phosphorylase (Option B):</strong> Non-specific; should refer to liver or muscle isoforms.</p>\n<p><strong>Glucose-6-phosphatase (Option C):</strong> Deficient in <strong>Von Gierke disease (GSD I)</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Pompe disease = Lysosomal &alpha;-1,4-glucosidase (acid maltase) deficiency with cardiac involvement.</strong></p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactase</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Fructokinase</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactokinase</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactose-1-phosphate uridyl transferase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A neonate delivered via normal vaginal delivery is started on mother's milk. Soon after, he develops vomiting, hypoglycemia, oil drop cataract, hepatomegaly, and mild icterus. Urine is positive for reducing substances but negative for glucose. What is the most likely enzyme deficiency?</span></p>",
      "unique_key": "DT1230369",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230369,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This clinical picture is classic for <strong>Galactosemia</strong>, particularly <strong>Classic Galactosemia</strong>, due to deficiency of <strong>galactose-1-phosphate uridyl transferase (GALT)</strong>.</p>\n<ul>\n<li>Symptoms begin <strong>after initiation of milk feeds</strong> (which contain lactose = glucose + galactose)</li>\n<li>Features include:\n<ul>\n<li><strong>Hypoglycemia</strong></li>\n<li><strong>Vomiting and feeding difficulty</strong></li>\n<li><strong>Hepatomegaly and jaundice</strong></li>\n<li><strong>Oil-drop cataracts</strong></li>\n<li><strong>Sepsis risk (especially E. coli)</strong></li>\n</ul>\n</li>\n<li><strong>Urine shows non-glucose reducing substances</strong>, confirmed by Benedict's test</li>\n<li>Diagnosis: Enzyme assay of GALT in red blood cells<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907d3eedbff-9cb3-4e5c-9e69-1068ff1f180b.png\"></li>\n<li>Management: <strong>Lactose-free, galactose-free diet</strong> started immediately</li>\n<li>If untreated, it may lead to <strong>death</strong> from liver/kidney failure or <strong> coli sepsis</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509075a56d6ae-8b88-4e56-8c31-ea3a691faccf.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lactase (Option A):</strong> Causes lactose intolerance, not hepatomegaly or cataracts</p>\n<p><strong>Fructokinase (Option B):</strong> Causes essential fructosuria, benign</p>\n<p><strong>Galactokinase (Option C):</strong> Causes isolated cataracts, no systemic signs</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Classic galactosemia is due to galactose-1-phosphate uridyl transferase deficiency, presenting with vomiting, hypoglycemia, cataracts, and hepatomegaly.</strong></p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">GSD type II</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">GSD type III</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">GSD type V</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">GSD type VI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old boy who plays left tackle for his high school football team complains of cramping in his muscles after practice. You, as the team physician, dig a bit further and find that he has experienced several such episodes, usually after fairly strenuous practices. Laboratory evaluation shows normal glucose at 97 mg/dL, normal blood urea nitrogen (BUN) of 12 mg/dL, and normal creatinine at 1.0 mg/dL. His creatine kinase (CK) was markedly elevated at 2216 IU/L. The patient denies use of performance-enhancing substances, and a urine drug screen is normal. You wonder about a glycogen storage disease as a cause of his problems. Which of the following is the most likely cause of this patient's findings?</span></p>",
      "unique_key": "DT1230401",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230401,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Muscle cramps with elevated CK after exertion strongly suggest GSD type V (McArdle disease).</strong></p>\n<ul>\n<li>GSD V (McArdle disease) is a myopathic glycogen storage disorder caused by <strong>myophosphorylase deficiency</strong>.</li>\n<li>Characterized by <strong>exercise-induced muscle cramps</strong>, fatigue, and risk of <strong>rhabdomyolysis</strong> with <strong>markedly elevated creatine kinase (CK)</strong>.</li>\n<li>Onset usually in adolescence or early adulthood, especially triggered by <strong>strenuous activity</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090784046f3d-27d5-46ed-99fb-fa48a3ef7165.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>GSD type II (Option A):</strong> Pompe disease; lysosomal; affects skeletal &amp; cardiac muscles-infantile form causes cardiomyopathy.</p>\n<p><strong>GSD type III (Option B):</strong> Cori disease; causes hepatosplenomegaly and myopathy-mainly liver involvement.</p>\n<p><strong>GSD type VI (Option D):</strong> Hers disease; mild liver form with hepatomegaly, not myopathy or exercise-induced symptoms.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Adolescent with exertional cramps and high CK suggests McArdle disease (GSD V), a myopathic glycogen storage disorder.</strong></p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatosplenomegaly</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarse facies</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysostosis multiplex</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked inheritance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following, except, characterise Hurler disease?</span></p>",
      "unique_key": "DT1230416",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230416,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Hurler syndrome follows <strong>autosomal recessive inheritance</strong>, not X-linked, hence option D is the correct answer.</p>\n<ul>\n<li>Hurler syndrome is a mucopolysaccharidosis type I (MPS I) caused by <strong>&alpha;-L-iduronidase deficiency</strong>.</li>\n<li>It is <strong>autosomal recessive</strong> and typically presents between 6-24 months.</li>\n<li>Clinical features include: <strong>coarse facies, hepatosplenomegaly, corneal clouding, large tongue, short stature, joint stiffness</strong>, and <strong>dysostosis multiplex</strong> on X-rays. <strong>(Option A, B, C)</strong></li>\n<li>Additional complications: cardiac valvular disease, obstructive airway disease, and recurrent infections.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509072a5701bf-ceb3-459f-a506-514d77b7277e.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Hurler syndrome is autosomal recessive</strong> and not X-linked; it presents with multisystem involvement including coarse facies, hepatosplenomegaly, and skeletal abnormalities.</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the Assertion and the Reason are correct</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the Assertion and the Reason are incorrect</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">The Assertion is correct, but the Reason is incorrect</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Reason is correct, but the Assertion is incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Assertion: Mousy odour occurs in patients with Phenylketonuria (PKU)<br>Reason: There is a decrease in tyrosine, dopamine, and noradrenaline in these patients, causing this odour</span></p>",
      "unique_key": "DT1230329",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230329,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The <strong>mousy (musty) odour</strong> in PKU is due to the accumulation and urinary excretion of <strong>phenylacetate</strong>, a by-product of elevated <strong>phenylalanine</strong>.</li>\r\n<li>The decrease in <strong>tyrosine, dopamine, and noradrenaline</strong> occurs due to deficient conversion of phenylalanine to tyrosine, but <strong>this is not the cause of the odour</strong>.</li>\r\n<li><strong>Phenylalanine hydroxylase</strong> deficiency is the primary defect in classical PKU, requiring tetrahydrobiopterin (BH4) as a cofactor.</li>\r\n<li>Unconverted phenylalanine is shunted to <strong>phenylpyruvate, phenyllactate, and phenylacetate</strong>, all toxic to the brain.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Elevated phenylalanine is <strong>neurotoxic</strong>, causing irreversible <strong>brain damage</strong> if not treated early (before 3 weeks of life).</li>\r\n<li>Tyrosine is a precursor for <strong>dopamine and norepinephrine</strong>; its deficiency affects <strong>neurotransmitter synthesis</strong>.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509078d338aca-d824-4f32-aa62-c76f1e9d5346.png\">\r\n<h4>Management Summary:</h4>\r\n<ul>\r\n<li><strong>Low phenylalanine diet</strong> (protein-restricted)</li>\r\n<li><strong>Tyrosine supplementation</strong></li>\r\n<li><strong>BH4 (sapropterin) therapy</strong> in selected cases</li>\r\n<li><strong>Neonatal screening</strong> is mandatory in most countries</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20241007c7d33252-f813-4bd5-bd8e-bccef6aaa4a1.jpg\">\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Mousy odour in PKU is due to phenylacetate, not catecholamine deficiency.</strong></p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisic acid oxidase</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoacid decarboxylase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An infant is brought to the hospital because her wet diaper turns black on exposure to air. Physical examination is otherwise normal. This condition is caused by a deficiency of which of the following enzymes?</span></p>",
      "unique_key": "DT1230377",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230377,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The <strong>blackening of urine upon standing</strong> in a neonate is a <strong>classic early clue</strong> for <strong>Alkaptonuria</strong>, a rare autosomal recessive disorder.</p>\n<ul>\n<li>Caused by a deficiency of <strong>homogentisate 1,2-dioxygenase</strong>, also known as <strong>homogentisic acid oxidase</strong>, an enzyme in the <strong>tyrosine degradation pathway</strong>.</li>\n<li>Leads to the accumulation of <strong>homogentisic acid</strong>, which is excreted in urine.</li>\n<li>On exposure to <strong>air</strong>, homogentisic acid <strong>oxidises and polymerises</strong>, turning urine <strong>black</strong>.</li>\n<li>Infants are otherwise asymptomatic; the black-stained <strong>diapers</strong> often lead to diagnosis.</li>\n<li>Long-term features in adulthood include <strong>ochronosis</strong> (bluish-black pigmentation of connective tissues) and <strong>degenerative arthritis</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907b8e94a5f-5d61-4244-92f9-8b667f2b6a4f.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phenylalanine hydroxylase (Option A):</strong> Deficient in <strong>PKU</strong>, which presents with musty odour and neurotoxicity, not black urine.</p>\n<p><strong>Ketoacid decarboxylase (Option C):</strong> Deficient in <strong>Maple Syrup Urine Disease</strong>, causing encephalopathy and sweet urine odour.</p>\n<p><strong>Tyrosinase (Option D):</strong> Deficient in <strong>Albinism</strong>, leading to hypopigmentation.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Microcephaly</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Abnormal EEG</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Glaucoma</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Eczematous skin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are features of untreated phenylketonuria except?</span></p>",
      "unique_key": "DT1230400",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230400,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>By 1 year of age,<strong> microcephaly, eczematous or oily skin, hypertonicity, convulsions, dysphasia, hyperactivity </strong>with purposeless movements, and an <strong>abnormal EEG</strong> are usual. <strong>(Option A, B,</strong><strong> C)</strong></p>\n<ul>\n<li>In early infancy, <strong>vomiting may mimic pyloric stenosis</strong>. The skin and hair are often fair, with blue eyes.</li>\n<li><strong>Psychotic </strong><strong>behaviour </strong>with <strong>hyperactivity, destructiveness, self-injury, impulsiveness and uncontrolled </strong><strong>behaviour</strong> is noted. The general physical development is usually good. Patients with PKU who are <strong>treated </strong>early generally <strong>have intelligence</strong> within the normal range. <strong>Hyperactivity</strong> and a lower IQ than a first-degree relative have been noticed in many patients with <strong>PKU</strong>. The frequency of abnormalities associated with EEG and MRI increases with age. <strong>Demyelination </strong>is almost<strong> universal in older patients </strong>affected with both <strong>classical PKU </strong><strong>and HPA type II.</strong></li>\n<li><strong>Plasma phenylalanine</strong>is elevated, and phenylalanine and its metabolites appear in the urine. <strong>Phenylacetic acid </strong>accounts for the subtle mousy, musty odour of these patients.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Glaucoma is not associated with phenylketonuria, unlike microcephaly, seizures, and eczematous skin.</strong></p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma amino acid concentrations</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma ammonia level</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma glucose</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma free fatty acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-day-old infant presents to the Emergency Department for lethargy. Parents report that he has had irritability and poor feeding for two days, with occasional vomiting. Today, he became difficult to arouse. He is the product of a full-term gestation and has been exclusively formula fed. Physical exam reveals a lethargic neonate whose urine smells like burnt sugar syrup. Which of the following is most likely to confirm the diagnosis?</span></p>",
      "unique_key": "DT1230412",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230412,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Plasma amino acid profiling confirms maple syrup urine disease (MSUD) by detecting elevated branched-chain amino acids.</p>\n<ul>\n<li>MSUD is an <strong>autosomal recessive disorder</strong> caused by <strong>branched-chain &alpha;-ketoacid dehydrogenase complex deficiency</strong>.</li>\n<li>The characteristic <strong>burnt sugar odour of urine</strong> is due to the accumulation of isoleucine and its metabolites.</li>\n<li>Classically presents in the <strong>first week of life</strong> with <strong>lethargy, vomiting, irritability, seizures, and encephalopathy</strong>.</li>\n<li><strong>Plasma amino acid analysis</strong> shows elevated <strong>leucine, isoleucine, valine</strong>, and <strong>alloisoleucine</strong> (diagnostic marker).</li>\n<li>Diagnosis should be confirmed urgently as the disease can rapidly progress to coma and death.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907dc309412-f885-4c3e-b0e9-fcd11a9be7ac.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Plasma ammonia level (Option B):</strong> Elevated in urea cycle disorders, not specific for MSUD.</p>\n<p><strong>Plasma glucose (Option C):</strong> To rule out hypoglycemia, but not diagnostic for MSUD.</p>\n<p><strong>Plasma free fatty acid (Option D):</strong> Assesses fatty acid oxidation defects, not helpful in MSUD.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>In a neonate with encephalopathy and urine smelling like burnt sugar, <strong>plasma amino acid concentration</strong> is the most diagnostic investigation for <strong>Maple Syrup Urine Disease</strong>.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Homocystinuria</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">CAH</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylketonuria</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkaptonuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6 administration is helpful in which among the following metabolic disorders?</span></p>",
      "unique_key": "DT1230423",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230423,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Vitamin B6 (pyridoxine) therapy is beneficial in many patients with <strong>homocystinuria</strong> due to cystathionine &beta;-synthase deficiency. Pyridoxine-responsive individuals tend to have milder disease and better outcomes. Methionine restriction and maintaining plasma homocysteine levels are also essential parts of therapy.</p>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>Homocystinuria is a disorder of methionine metabolism.</li>\n<li>Some patients respond to high-dose vitamin B6 (up to 200-500 mg/day).</li>\n<li>Vitamin B6 acts as a cofactor for cystathionine &beta;-synthase enzyme.</li>\n<li>Pyridoxine responsiveness is assessed by a therapeutic trial over a few weeks.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>CAH (Option B):</strong> Treated with hydrocortisone or other glucocorticoids; not responsive to vitamin B6.</p>\n<p><strong>Phenylketonuria (Option C):</strong> Managed by dietary restriction of phenylalanine; no role for pyridoxine.</p>\n<p><strong>Alkaptonuria (Option D):</strong> Treated with nitisinone and low-protein diet; vitamin B6 has no role.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Pyridoxine responsiveness is a key feature in certain subtypes of homocystinuria but not in other common inborn errors of metabolism.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal saline @ 10 mL/kg over 1 hr with insulin bolus</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal saline @ 20 mL/kg over 1 hr with insulin bolus</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal saline @ 10 mL/kg over 1 hr with insulin later</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal saline @ 20 mL/kg over 1 hr with insulin later</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child with known type 1 diabetes mellitus presents to the emergency room unconscious, with acidotic breathing, arterial pH of 7.2, blood glucose of 550 mg/dL, and urine ketones 3+. What is the most appropriate immediate management?</span></p>",
      "unique_key": "DT1230335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The child is in <strong>severe diabetic ketoacidosis (DKA)</strong>, evident from:</p>\n<ul>\n<li>Depressed consciousness</li>\n<li>Arterial pH of 7.2</li>\n<li>High blood glucose (&gt;300 mg/dL)</li>\n<li>Positive ketonuria</li>\n<li>Dehydration and acidotic breathing</li>\n</ul>\n<p>According to <strong>AIIMS PICU Protocols 2022</strong>, management principles for DKA include:</p>\n<ul>\n<li><strong>Fluid resuscitation before insulin</strong></li>\n<li>For <strong>severe DKA</strong> (pH &lt; 7.15 or altered sensorium), <strong>20 mL/kg of normal saline over 30-60 minutes</strong> is recommended</li>\n<li><strong>Insulin infusion</strong> (not bolus) is started <strong>only after initial fluid correction</strong>, typically at 0.05-0.1 U/kg/hr IV</li>\n<li>Giving insulin before hydration or as a bolus can precipitate <strong>cerebral oedema</strong> and is contraindicated</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907d873e7a4-df8f-4d17-bc02-03747b95df7c.png\">\n<ul>\n<li>Dextrose is added later to prevent hypoglycemia as glucose levels fall.</li>\n<li>Monitor electrolytes, especially <strong>potassium</strong>, closely.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Normal saline @ 10 mL/kg over 1 hr with insulin bolus</strong> (<strong>Option A):</strong> 10 mL/kg is insufficient for severe DKA; insulin bolus is incorrect.</p>\n<p><strong>Normal saline @ 20 mL/kg over 1 hr with insulin bolus</strong> (<strong>Option B):</strong> Correct fluid amount, but <strong>insulin bolus</strong> is contraindicated.</p>\n<p><strong>Normal saline @ 10 mL/kg over 1 hr with insulin later </strong>(<strong>Option C):</strong> Correct insulin timing, but the fluid bolus is inadequate for severe DKA.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>In severe DKA, initiate resuscitation with 20 mL/kg NS over 1 hour, and start insulin infusion only after hydration.</strong></p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer a normal saline bolus</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer a potassium binder</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer subcutaneous insulin</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer intravenous insulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Upon presentation to the emergency department, a 7-year-old girl is found to have a serum glucose concentration of 700 mg/dL, a pH of 7.15, bicarbonate of 13 mEq/L, and a potassium of 6.6 mEq/L. What is the first step in treatment?</span></p>",
      "unique_key": "DT1230409",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230409,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Initial fluid resuscitation with normal saline is the first and most crucial step in managing pediatric DKA.</strong></p>\n<ul>\n<li>Children in DKA are <strong>dehydrated</strong> due to osmotic diuresis.</li>\n<li>The priority is to restore intravascular volume to improve perfusion and reduce counterregulatory stress hormones (e.g., cortisol, epinephrine).</li>\n<li><strong>Fluids alone</strong> can lead to a rapid decrease in blood glucose even before insulin is started.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090794967399-f5b0-4ac5-8cd7-14e56f545e2f.png\"></li>\n<li><strong>Insulin</strong> is started <strong>after</strong> initial fluids: 0.05-0.1 U/kg/hr IV infusion (no bolus).</li>\n<li><strong>Potassium</strong> is added to IV fluids once urine output is confirmed and after initial hydration.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Administer a potassium binder (Option B):</strong> Not indicated; initial hyperkalemia is misleading due to acidosis, and total body potassium is depleted.</p>\n<p><strong>Administer subcutaneous insulin (Option C):</strong> Not recommended in DKA due to unpredictable absorption; IV insulin is the standard.</p>\n<p><strong>Administer intravenous insulin (Option D):</strong> Should be started <strong>after</strong> initial fluid resuscitation, not immediately.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>In DKA, fluid resuscitation with normal saline precedes insulin administration to stabilise circulation and prevent complications like cerebral oedema.</strong></p>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue current therapy</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue intravenous insulin therapy and change IVF to D5 0.45% normal saline</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop intravenous insulin therapy and allow the patient to begin subcutaneous insulin administration</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop intravenous insulin therapy and administer bicarbonate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Thirty-six hours after initiation of treatment with insulin for DKA, a 4-year-old girl's serum glucose level is 240 mEq/L. Further laboratory work reveals a bicarbonate level of 16 mEq/L. She is currently receiving 0.1 units/kg/h of regular insulin as well as normal saline. What is the next step in treatment?</span></p>",
      "unique_key": "DT1230474",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230474,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Although the <strong>patient's serum glucose</strong>is decreasing, her metabolic acidosis has not yet resolved and will require <strong>continued intravenous insulin therapy and IV Fluid for treatment.</strong></li>\n<li>The patient should not be <strong>converted to subcutaneous insulin </strong>until her glucose has normalized, he<strong>r bicarbonate level is greater than 18 mEq/L, and her serum pH is greater than 7.3. </strong>Because of the risk of causing <strong>hypoglycemia </strong>with continued insulin therapy, dextrose should be added to her fluids.</li>\n<li><strong>Bicarbonate therap</strong>y has not been shown to be effective in the treatment of metabolic acidosis associated with DKA and can actually be harmful.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509078750429c-c74e-4e0d-9115-54b80722a20f.png\"></li>\n<li><strong>Bicarbonate therapy</strong> is avoided due to risk of <strong>cerebral edema</strong> and paradoxical CNS acidosis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Continue current therapy (Option A):</strong> Continuing without changing fluids risks <strong>hypoglycemia</strong>.</p>\n<p><strong>Stop intravenous insulin therapy and allow the patient to begin subcutaneous insulin administration (Option C):</strong> Switching to SC insulin is <strong>premature</strong> as acidosis persists.</p>\n<p><strong>Stop intravenous insulin therapy and administer bicarbonate (Option D):</strong> Bicarbonate use is not recommended in pediatric DKA unless <strong>severe acidosis with cardiac compromise</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Continue IV insulin until acidosis resolves; add dextrose when glucose &lt;250 mg/dL to prevent hypoglycemia.</strong></p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediately at diagnosis</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">After 3 years</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">After 10 years</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Not needed in Type 2 DM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In an 8-year-old child recently diagnosed with type 1 DM, when should the first evaluation for diabetic retinopathy done?</span></p>",
      "unique_key": "DT1230425",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230425,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>For children with Type 1 DM, retinopathy screening is recommended after 3&ndash;5 years of diagnosis, but not before age 10.</p>\n<ul>\n<li>Diabetic retinopathy is rare before puberty and before 5 years of diabetes duration.</li>\n<li>Hence, screening in <strong>Type 1 DM</strong> should begin:\n<ul>\n<li>3-5 years after diagnosis</li>\n<li>Only if the child is &ge;10 years of age</li>\n</ul>\n</li>\n<li><strong>For Type 2 DM</strong>, retinal screening should be done <strong>at diagnosis</strong>, as many are already hyperglycemic for a long time before being diagnosed.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090709c774a5-6977-4609-881b-ac69d733f730.png\"></li>\n<li>Children with <strong>visual complaints</strong> or <strong>abnormal findings</strong> should be referred immediately, regardless of duration.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>In children with Type 1 DM, retinopathy screening starts after 3-5 years of diagnosis, but not before age 10.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal haemorrhage</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Wolman disease</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-month-old infant is brought in with failure to thrive, recurrent vomiting, hepatosplenomegaly, and adrenal insufficiency. Radiology reveals bilateral adrenal calcifications. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1230346",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230346,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The triad of <strong>hepatosplenomegaly</strong>, <strong>adrenal insufficiency</strong>, and <strong>adrenal calcification</strong> in a sick neonate is classic for <strong>Wolman disease</strong>.</p>\n<ul>\n<li>Wolman disease is a rare, autosomal recessive lysosomal storage disorder caused by a deficiency of lysosomal acid lipase (LAL).</li>\n<li>Leads to the accumulation of triglycerides and cholesterol esters in macrophages of multiple organs (liver, spleen, adrenals).</li>\n<li>Clinical signs usually appear within the first few weeks of life and include:\n<ul>\n<li>Refractory vomiting</li>\n<li>Failure to thrive</li>\n<li>Massive hepatosplenomegaly</li>\n<li>Adrenal calcification (seen in ~50% cases)</li>\n<li>Hyperlipidemia, steatorrhea</li>\n</ul>\n</li>\n</ul>\n<p>Without treatment, death occurs within 6 months, usually due to liver failure or sepsis.</p>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li><strong>Gene: LIPA (LAL) gene on chromosome 10q24-q25</strong></li>\n<li><strong>Diagnosis:</strong> Enzyme assay (LAL activity) or molecular testing</li>\n<li><strong>Treatment:</strong> Enzyme replacement therapy (sebelipase alfa) is under trial</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Adrenal haemorrhage (Option A):</strong> May cause calcification, but is usually unilateral and occurs post-trauma/birth injury.</p>\n<p><strong>Pheochromocytoma (Option C):</strong> Extremely rare in infancy; presents with hypertension, not vomiting.</p>\n<p><strong>Addison's disease (Option D):</strong> Causes adrenal insufficiency but is not associated with adrenal calcification or hepatosplenomegaly.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Wolman disease = Infant with FTT, vomiting, hepatosplenomegaly, adrenal insufficiency, and adrenal calcification.</strong></p>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler syndrome</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylketonuria</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">GM1 gangliosidoses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are evaluating a child with obesity, failure to thrive, and low IQ. The child has coarse facial features. Which of the following disorders is least likely to be associated with this presentation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202410078301e6ce-cb3b-4e27-99e0-6014e39b1527.jpg\"></span></p>",
      "unique_key": "DT1230344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Coarse facies</strong> describes a combination of abnormal craniofacial features, including:</p>\n<ul>\n<li>Bulging forehead and veins</li>\n<li>Broad nasal bridge, saddle nose</li>\n<li>Thick lips and macroglossia</li>\n<li>Hypertrophied gums and malformed teeth</li>\n</ul>\n<p><strong>Common causes of coarse facies include:</strong></p>\n<ul>\n<li><strong>Mucopolysaccharidoses (e.g., Hurler, Hunter, Morquio)</strong></li>\n<li><strong>Severe congenital hypothyroidism</strong></li>\n<li><strong>GM1 gangliosidoses</strong></li>\n</ul>\n<p>In contrast, <strong>Phenylketonuria (PKU)</strong> presents with:</p>\n<ul>\n<li><strong>Fair skin, blue eyes, blond hair</strong></li>\n<li><strong>Normal facies</strong>, no coarseness</li>\n<li>Hypopigmentation due to lack of melanin (tyrosine deficiency)</li>\n</ul>\n<p>Thus, PKU is not associated with <strong>coarse facies</strong>, making it the correct exclusion.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509070ac98c38-f60b-4154-9782-e651a9d25f95.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hurler syndrome (Option A):</strong> Classical mucopolysaccharidosis with coarse facies.</p>\n<p><strong>Hypothyroidism (Option B):</strong> Causes puffy, coarse features with macroglossia.</p>\n<p><strong>GM1 gangliosidoses (Option D):</strong> Lipid storage disorder with coarse features.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Phenylketonuria presents with fair skin and hypopigmentation, not coarse facies.</strong></p>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Radionuclide scan</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary iodine concentration</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum TRAb estimation</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-TPO antibody estimation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-day-old neonate is found to have serum TSH >100 IU/L on newborn screening. What is the next best investigation?</span></p>",
      "unique_key": "DT1230350",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230350,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In a neonate with <strong>TSH &gt;100 IU/L</strong>, <strong>congenital hypothyroidism (CH)</strong> is strongly suspected. The <strong>next step</strong> is a <strong>radionuclide thyroid scan</strong> to determine thyroid location and function.</p>\n<ol>\n<li><strong>Abnormal TSH or T4</strong> &rarr; Perform <strong>radionuclide scan</strong></li>\n<li>Interpretation of scan results:\n<ul>\n<li><strong>No uptake</strong> &rarr; Do <strong>USG thyroid</strong>\n<ul>\n<li>If thyroid <strong>absent</strong> &rarr; <strong>Thyroid agenesis</strong></li>\n<li>If thyroid <strong>present,</strong> &rarr; Do <strong>TSH receptor antibody</strong> testing</li>\n</ul>\n</li>\n<li><strong>Ectopic uptake</strong> &rarr; <strong>Ectopic thyroid</strong></li>\n<li><strong>Increased uptake</strong> &rarr; Suggests <strong>dyshormonogenesis or iodine deficiency</strong></li>\n</ul>\n</li>\n</ol>\n<p>This scan helps classify the aetiology (agenesis, ectopy, or dyshormonogenesis), which is essential for prognosis and genetic counselling.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202410070ec685bf-01aa-4b67-b735-a8b0a1f5d641.jpg\">\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>Ideal tim<strong>e </strong>for newborn thyroid screening: After 48-72 hours of life</li>\n<li>Testing before 48 hours may yield false negatives due to a TSH surge</li>\n<li>Preferred samples: Heel prick on filter paper</li>\n</ul>\n<p><strong>Role of other tests:</strong></p>\n<ul>\n<li><strong>Urinary iodine (Option B):</strong> Done if maternal/infant iodine deficiency suspected</li>\n<li><strong>TRAb (Option C):</strong> Indicated if <strong>maternal Graves'</strong> is suspected</li>\n<li><strong>Anti-TPO (Option D):</strong> Associated with autoimmune hypothyroidism in older children, not neonates</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Radionuclide scan</strong> is the next best step to determine thyroid anatomy and function in neonatal hypothyroidism.</p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Exophthalmos</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Sustained clonus</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Closed posterior fontanelle</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolonged jaundice</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During his first physical examination following birth at home with the assistance of a midwife, a 5-week-old male is suspected to have congenital hypothyroidism. His parents refused all newborn screening at the time of his birth. Which of the following may be the earliest clinical sign of congenital hypothyroidism?</span></p>",
      "unique_key": "DT1230407",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230407,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Prolonged physiological jaundice is often the earliest clinical sign in congenital hypothyroidism.</strong></p>\n<ul>\n<li>It results from <strong>delayed maturation of hepatic glucuronyl transferase</strong>, impairing bilirubin conjugation.</li>\n<li>This subtle sign may precede more obvious features and is often missed without newborn screening.</li>\n<li>Congenital hypothyroidism is a <strong>common preventable cause of intellectual disability</strong> if untreated early.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090713fbc20e-b63b-45ce-b1af-b6e1943b7203.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Exophthalmos (Option A):</strong> Seen in hyperthyroidism, not hypothyroidism.</p>\n<p><strong>Sustained clonus (Option B):</strong> Suggests upper motor neuron lesion, not typical of hypothyroidism.</p>\n<p><strong>Closed posterior fontanelle (Option C):</strong> Hypothyroidism often causes <strong>delayed</strong> closure, not early.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Prolonged neonatal jaundice should raise suspicion for congenital hypothyroidism, especially when newborn screening is missed.</p>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">FNAC</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound neck</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">TBG level</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">TPO antibody titer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old boy presents with enlargement of the thyroid gland. His TSH is low at 2 mIU/l, his T4 is 29&mu;g/l, and he is positive for TSH receptors ABC. A thyroid scan indicates a single large cold nodule, and a neck ultrasound indicates a solid thyroid gland. Next investigation?</span></p>",
      "unique_key": "DT1230410",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230410,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Any solid cold thyroid nodule in children, especially with suspicious features on ultrasound, requires FNAC to rule out malignancy.</p>\n<ul>\n<li>Though ultrasound and TIRADS scoring guide biopsy decisions, children with cold nodules on scintigraphy and solid lesions on ultrasound are at higher risk of malignancy.</li>\n<li>The presence of positive TSH receptor antibodies (suggesting Graves') doesn't rule out malignancy in a discrete cold nodule.</li>\n<li>Per Nelson and OP Ghai, FNAC is the next best step if a cold nodule is seen in a euthyroid or hyperthyroid child and TIRADS 4/5 features or a solid nodule is seen.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202410073afc4d7c-f22d-4002-ad09-34fd33efb03d.jpg\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Ultrasound neck (Option B):</strong> Already done; repeat not required unless features were unclear.</p>\n<p><strong>TBG level (Option C):</strong> Irrelevant; total T4 already interpreted in context.</p>\n<p><strong>TPO antibody titer (Option D):</strong> Useful in Hashimoto's, not indicated here for nodule evaluation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Solid cold nodules in children require FNAC if TIRADS 4/5 features are present, irrespective of thyroid antibody positivity.</strong></p>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotoxicosis</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohypoparathyroidism</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple obesity</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Gigantism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not associated with a period of excessive growth?</span></p>",
      "unique_key": "DT1230406",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230406,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Pseudohypoparathyroidism is associated with short stature, not excessive growth.</strong></p>\n<ul>\n<li>It is a <strong>hormone resistance disorder</strong> involving end-organ resistance to PTH, often associated with <strong>Albright hereditary osteodystrophy</strong>, which includes short stature, obesity, round face, and subcutaneous calcifications.</li>\n<li>Unlike other conditions listed, it does <strong>not promote linear overgrowth</strong>.</li>\n</ul>\n<p>Causes of excessive growth in childhood</p>\n<ul>\n<li><strong>Nonendocrine Causes</strong>\n<ul>\n<li>Familial (constitutional) tall stature</li>\n<li>Exogenous obesity <strong>(Option </strong><strong>C)</strong></li>\n<li><strong>Cerebral gigantism (Sotos syndrome)</strong></li>\n<li>Weaver syndrome</li>\n<li>Marfan syndrome</li>\n<li>Fragile X syndrome</li>\n<li><strong>Beckwith-Wiedemann syndrome</strong></li>\n<li><strong>Klinefelter syndrome (XXY)</strong></li>\n<li>SHOX excess syndromes</li>\n<li>Homocystinuria</li>\n<li>XYY</li>\n</ul>\n</li>\n<li><strong>Endocrine Causes</strong>\n<ul>\n<li>Excess GH secretion (pituitary gigantism)<strong> (Option </strong><strong>D)</strong></li>\n<li><strong>McCune-Albright syndrome or MEN </strong><strong>is associated with excess GH</strong></li>\n<li>secretion</li>\n<li>Precocious puberty</li>\n<li>Hyperthyroidism <strong>(Option A)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Pseudohypoparathyroidism causes short stature, unlike other listed conditions that are associated with excessive growth.</p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler syndrome (MPS I)</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Hunter syndrome (MPS II)</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Sanfilippo syndrome (MPS III)</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Morquio syndrome (MPS IV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The mucopolysaccharidoses (MPS) are a group of inherited disorders caused by defects in the catabolism of glycosaminoglycans (GAGs). Which one of the following MPS disorders is inherited in an X-linked manner?</span></p>",
      "unique_key": "DT1230338",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Among all MPS types, <strong>only Hunter syndrome (MPS II)</strong> follows <strong>X-linked recessive inheritance</strong>. All others are <strong>autosomal recessive</strong>.</p>\n<ul>\n<li>MPS disorders are caused by <strong>lysosomal enzyme deficiencies</strong> that impair the degradation of <strong>glycosaminoglycans (heparan sulfate, dermatan sulfate, etc.)</strong></li>\n<li><strong>Hunter syndrome</strong> presents similarly to Hurler syndrome but <strong>lacks corneal clouding</strong> and follows an <strong>X-linked pattern</strong>.</li>\n<li><strong>Genetic counselling</strong> and <strong>carrier testing</strong> are essential in families with affected males.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090764d06f71-4f74-4a7f-9613-a4957f1e2129.png\">\n<ul>\n<li>Clinical features include coarse facies, hepatosplenomegaly, skeletal dysplasia, and developmental delay.</li>\n<li>Corneal clouding helps differentiate <strong>Hurler (present)</strong> from <strong>Hunter (absent)</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hurler syndrome (Option A):</strong> Autosomal recessive, with corneal clouding.</p>\n<p><strong>Sanfilippo syndrome (Option C):</strong> Autosomal recessive, affects CNS predominantly.</p>\n<p><strong>Morquio syndrome (Option D):</strong> Autosomal recessive, mainly skeletal involvement.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Hunter syndrome (MPS II) is the only X-linked MPS disorder; others are autosomal recessive.</strong></p>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzyme replacement therapy (ERT)</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical referral for splenectomy</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow transplantation</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver transplantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most effective treatment for the hematologic complications seen in Gaucher disease?</span></p>",
      "unique_key": "DT1230356",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Gaucher disease is the most common <strong>lysosomal storage disorder</strong>, caused by a deficiency of the enzyme <strong>&beta;-glucocerebrosidase</strong> (also known as acid &beta;-glucosidase), leading to the accumulation of <strong>glucocerebroside</strong> in macrophages of the liver, spleen, and bone marrow.</p>\n<ul>\n<li><strong>ERT using recombinant glucocerebrosidase</strong> (e.g., imiglucerase) reverses:\n<ul>\n<li><strong>Anemia</strong></li>\n<li><strong>Thrombocytopenia</strong></li>\n<li><strong>Organomegaly</strong></li>\n<li><strong>Skeletal involvement (early stages)</strong></li>\n</ul>\n</li>\n<li><strong>Given biweekly IV infusions</strong>, it dramatically improves quality of life and reduces disease burden.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509074a688af0-352e-437a-9bc1-d3c389472bca.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Surgical referral for splenectomy (Option B):</strong> Reserved for massive splenomegaly with cytopenia unresponsive to ERT.</p>\n<p><strong>Bone marrow transplantation (Option C):</strong> Rarely used; high morbidity.</p>\n<p><strong>Liver transplantation (Option D):</strong> Not indicated for Gaucher disease.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>ERT with recombinant glucocerebrosidase</strong> is the gold standard treatment for hematologic complications in Gaucher disease.</p>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase-A</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Iduronidate-2-sulphatase</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-Phosphatase</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with anaemia, mental retardation, bone pains and hepatosplenomegaly. Bone marrow biopsy showed a \"crumpled tissue paper\" appearance. What is the enzyme deficiency producing this condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20241007cda06d24-5a3d-4ebd-ab04-450adb82b9bb.jpg\"></span></p>",
      "unique_key": "DT1230363",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Presence of <strong>anaemia, hepatosplenomegaly, </strong>low IQ, bone pains and <strong>crumpled tissue paper </strong>appearance on BM biopsy suggests a diagnosis of <strong>Gaucher's Disease.</strong> The cause isa deficiency of <strong>Glucocerebrosidase enzyme.</strong></p>\n<p>Key points to remember regarding <strong>Gaucher's Disease</strong></p>\n<ul>\n<li>MC lysosomal storage disease</li>\n<li>Inheritance: <strong>Autosomal recessive &rarr; Gene on 1q</strong></li>\n<li>Deficient enzyme: <strong>Glucocerebrosidase</strong>, also called <strong>Acid </strong><strong>&beta;-glucosidase</strong></li>\n<li>This causes the accumulation of glucocerebrosides in the reticulo-endothelial system</li>\n<li>BM biopsy shows <strong>PAS +ve swollen cells with vacuoles, eccentric nuclei</strong>, giving a <strong>Crumpled/Wrinkled Tissue Paper</strong>Appearance, called <strong><u>Gaucher Cells</u></strong></li>\n<li><strong>Enzyme Replacement Therapy (ERT)</strong>is now commercially available.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hexosaminidase-A (Option A): </strong>Deficient in Tay-Sachs disease; presents with cherry red spot and no hepatosplenomegaly.</p>\n<p><strong>Iduronate-2-sulfatase (Option B): </strong>Deficient in Hunter syndrome (MPS II); causes coarse facies and joint contractures.</p>\n<p><strong>Glucose-6-phosphatase (Option C): </strong>Deficient in Von Gierke disease (GSD I); causes hypoglycemia and hepatomegaly, not bone pain or Gaucher cells.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Gaucher disease = Glucocerebrosidase deficiency + Gaucher cells (\"crumpled tissue paper\" appearance).</p>",
      "correct_choice_id": 284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Infantile Gaucher disease</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuronal ceroid lipofuscinosis</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick type A</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-month-old girl is brought in by her mother with the complaint of progressive weakness and poor head control. She has also noted that her daughter appears less attentive and has an exaggerated startle response. Results of examination are unremarkable except for diffuse hypotonia. There is no hepatosplenomegaly. She has a good suck and swallow, and she flexes and follows intermittently. As part of a comprehensive evaluation, she is seen by a pediatric ophthalmologist who notes slightly impaired visual acuity as well as following fundus examination. Of the following, the MOST likely diagnosis for this child is?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20241007ba5f9214-1969-4697-929e-e6fde90d5b20.jpg\"></span></p>",
      "unique_key": "DT1230398",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230398,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Infants with <strong>Tay-Sachs's disease </strong>appear normal at birth, but progressive weakness and an exaggerated startle response are typically noted by <strong>4 to 6 months of age</strong><strong>, </strong>followed by a progressive deterioration.</p>\n<ul>\n<li>The diagnosis of TSD is made by <strong>hexosaminidase A assay.</strong></li>\n<li>Although <strong>cherry-red spots </strong>may also be seen in some infants with infantile <strong>Gaucher disease and Niemann-Pick type A</strong>, a child with infantile Gaucher disease or Niemann-Pick type A would typically exhibit <strong>hepatosplenomegaly</strong>.</li>\n<li>TA ay-Sachs Disease patient does not have hepatosplenomegaly, but shows a <strong>cherry red spot very often, </strong>along with hypotonia.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Infantile Gaucher disease (Option A):</strong> Usually presents with <strong>organomegaly</strong>, bone involvement, and neuroregression.</p>\n<p><strong>Neuronal ceroid lipofuscinosis (Option B):</strong> Later onset, progressive vision loss, and seizures-not prominent at 4 months.</p>\n<p><strong>Niemann-Pick type A (Option C):</strong> Also shows cherry-red spot, but always has <strong>hepatosplenomegaly</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Tay-Sachs disease = cherry-red spot + neuroregression + no hepatosplenomegaly.</p>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay Sachs disease</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher disease</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann Pick disease</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child was brought with mental retardation. He had a cherry-red spot with no organomegaly. What is the probable diagnosis?</span></p>",
      "unique_key": "DT1230418",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Cherry-red spot on fundus with neuroregression and absence of organomegaly is classic for Tay-Sachs disease.</p>\n<ul>\n<li>Tay-Sachs is a GM2 gangliosidosis caused by <strong>hexosaminidase A deficiency</strong>.</li>\n<li>Neurodegeneration begins by 4-6 months: decreased eye contact, hyperacusis (exaggerated startle), and loss of motor milestones.</li>\n<li>Fundus shows <strong>macular pallor with central cherry-red spot</strong>.</li>\n<li>No hepatosplenomegaly (which helps differentiate from Niemann-Pick).</li>\n<li>Progressive deterioration leads to seizures, blindness, spasticity, and death by 4-5 years.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907734b54bc-dd0d-4bf8-a009-cf2ee0258f73.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Gaucher disease (Option B):</strong> Shows hepatosplenomegaly, bone crisis, and \"crumpled tissue paper\" cells, not cherry-red spot.</p>\n<p><strong>Niemann Pick disease (Option C):</strong> Also presents with cherry-red spot but has <strong>hepatosplenomegaly</strong>.</p>\n<p><strong>Hurler disease (Option D):</strong> Mucopolysaccharidosis with coarse facies, corneal clouding, and organomegaly not associated with cherry-red spot.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Cherry-red spot with neurodegeneration and absence of hepatosplenomegaly is diagnostic of <strong>Tay-Sachs disease</strong>.</p>",
      "correct_choice_id": 301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Rickets</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteomalacia</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteogenesis imperfecta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young boy presents with blue sclera and excessively fragile bones prone to repeated fractures. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20241007c57590a3-58ca-4524-8302-eb311b4b633e.jpg\"></span></p>",
      "unique_key": "DT1230375",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The combination of <strong>blue sclera</strong> and <strong>brittle bones</strong> with multiple fractures is characteristic of <strong>Osteogenesis Imperfecta (OI)</strong>, also known as <strong>brittle bone disease</strong>.</p>\n<ul>\n<li>OI is a <strong>collagen synthesis disorder</strong>, most commonly involving <strong>Type I collagen</strong>, due to mutations in <strong>COL1A1 or COL1A2 </strong>genes.</li>\n<li><strong>Type I OI</strong> is the mildest and most common form:\n<ul>\n<li>Recurrent childhood fractures</li>\n<li><strong>Blue sclera</strong> due to thin collagen in the sclera, allowing visibility of the underlying uveal pigment</li>\n<li>Presenile <strong>conductive hearing loss</strong> (30-60% cases)</li>\n</ul>\n</li>\n<li>Severe forms (e.g., <strong>Type II</strong>) may cause <strong>intrauterine fractures</strong> and are often <strong>lethal in infancy</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Rickets (Option A):</strong> Causes metaphyseal cupping/fraying and deformities, not blue sclera.</p>\n<p><strong>Scurvy (Option B):</strong> Due to vitamin C deficiency, may cause subperiosteal haemorrhage but not blue sclera.</p>\n<p><strong>Osteomalacia (Option C):</strong> Adult counterpart of rickets; does not occur in children and does not present with blue sclera.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Osteogenesis Imperfecta = blue sclera + fragile bones + possible hearing loss (esp. in Type I).</p>",
      "correct_choice_id": 314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleiotropism</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudo-dominance</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Penetrance</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticipation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following terms refers to a single gene defect causing multiple unrelated clinical effects?</span></p>",
      "unique_key": "DT1230391",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230391,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Pleiotropism refers to a single gene mutation causing multiple, seemingly unrelated phenotypic effects across various systems.</p>\n<ul>\n<li>In pleiotropy, a mutation in one gene affects multiple organ systems or functions.</li>\n<li>The classic example is Marfan syndrome, where a mutation in the fibrillin-1 gene (FBN1) leads to:\n<ul>\n<li>Skeletal anomalies (arachnodactyly, tall stature)</li>\n<li>Cardiovascular defects (aortic root dilation)</li>\n<li>Ocular issues (lens dislocation)</li>\n</ul>\n</li>\n</ul>\n<p>Other examples:</p>\n<ul>\n<li><strong>Phenylketonuria (PKU)</strong>: One gene defect leads to mental retardation, hypopigmentation, and eczema</li>\n<li><strong>Sickle cell disease</strong>: Single mutation causes vaso-occlusion, anaemia, stroke, splenic infarction</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pseudo-dominance (Option B):</strong> When a <strong>recessive trait appears dominant</strong>, often due to consanguinity or deletion of the dominant allele.</p>\n<p><strong>Penetrance (Option C):</strong> The <strong>likelihood</strong> that a person carrying a mutant gene will express the trait phenotypically.</p>\n<p><strong>Anticipation (Option D):</strong> Seen in <strong>trinucleotide repeat disorders</strong>, where severity increases and onset is earlier in successive generations (e.g., Fragile X, Huntington's).</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Pleiotropism = One gene &rarr; multiple unrelated effects (e.g., Marfan syndrome).</strong></p>",
      "correct_choice_id": 321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">Fragile X syndrome</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">G6PD deficiency</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleft palate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following disorders is an example of polygenic (multifactorial) inheritance?</span></p>",
      "unique_key": "DT1230390",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230390,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Cleft palate is a well-known example of polygenic or multifactorial inheritance, where multiple genes and environmental factors contribute to the phenotype.</strong></p>\n<ul>\n<li>In <strong>polygenic/multifactorial disorders</strong>, <strong>no single gene</strong> is solely responsible; instead, <strong>multiple loci</strong> and <strong>external triggers</strong> (e.g., teratogens, maternal nutrition) determine expression.</li>\n<li>Recurrence risk is higher if:\n<ul>\n<li>The defect is severe</li>\n<li>More than one sibling is affected</li>\n<li>The less commonly affected sex is involved</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907fe3ba7ea-0f7e-4a13-a056-91ffd565cd27.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Fragile X syndrome (Option A):</strong> X-linked dominant with <strong>trinucleotide repeat expansion (CGG)</strong>.</p>\n<p><strong>G6PD deficiency (Option B):</strong> X-linked recessive enzyme defect; causes hemolysis.</p>\n<p><strong>Cystic fibrosis (Option C):</strong> Autosomal recessive; mutation in the <strong>CFTR gene</strong> on chromosome 7.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Cleft palate follows polygenic inheritance, unlike single-gene Mendelian disorders like CF or G6PD deficiency.</p>",
      "correct_choice_id": 334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}